Patients taking Eli Lilly's new drug Mounjaro achieved significantly greater weight loss than those on Novo Nordisk's Ozempic ...
Eli Lilly and Company is set to acquire Morphic Holding for $3.2bn. Morphic is focused on autoimmune disease drugs.
Eli Lilly has agreed to acquire Morphic Therapeutic for $3.2 billion, in a deal designed to expand the buyer’s chronic ...
Eli Lilly and Co. said Monday it has agreed to buy a Massachusetts-based biopharmaceutical company that is developing ...
Eli Lilly & Co. acordó comprar Morphic Holding Inc., fabricante estadounidense de fármacos para el intestino, por alrededor ...
Eli Lilly has agreed to buy Morphic for $3.2 billion, giving the Big Pharma control of an oral, midphase challenger to Takeda ...
(Bloomberg) — Eli Lilly agreed to buy Waltham-based gut-drug maker Morphic Holding Inc. for about $3.2 billion, plowing some ...
Chicago, IL – July 8, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results